药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tasosartan
Bacillus calmette-guerin substrain danish 1331 live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Palbociclib.
Tasosartan
Typhoid Vaccine Live
The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Palbociclib.
Tasosartan
Anthrax vaccine
The risk or severity of infection can be increased when Anthrax vaccine is combined with Palbociclib.
Tasosartan
Yellow Fever Vaccine
The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Palbociclib.
Tasosartan
Bacillus calmette-guerin substrain connaught live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Palbociclib.
Tasosartan
Bacillus calmette-guerin substrain tice live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Palbociclib.
Tasosartan
Varicella Zoster Vaccine (Live/attenuated)
The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Palbociclib.
Tasosartan
Rubella virus vaccine
The risk or severity of infection can be increased when Rubella virus vaccine is combined with Palbociclib.
Tasosartan
Lipegfilgrastim
Palbociclib may increase the myelosuppressive activities of Lipegfilgrastim.
Tasosartan
Pitolisant
The serum concentration of Palbociclib can be decreased when it is combined with Pitolisant.
Tasosartan
Betrixaban
The serum concentration of Betrixaban can be increased when it is combined with Palbociclib.
Tasosartan
Naftopidil
The risk or severity of bleeding can be increased when Naftopidil is combined with Palbociclib.
Tasosartan
Tranilast
The risk or severity of bleeding can be increased when Tranilast is combined with Palbociclib.
Tasosartan
Nimesulide
The risk or severity of bleeding can be increased when Nimesulide is combined with Palbociclib.
Tasosartan
Relcovaptan
The risk or severity of bleeding can be increased when Relcovaptan is combined with Palbociclib.
Tasosartan
Buflomedil
The risk or severity of bleeding can be increased when Buflomedil is combined with Palbociclib.
Tasosartan
Linsidomine
The risk or severity of bleeding can be increased when Linsidomine is combined with Palbociclib.
Tasosartan
Cloricromen
The risk or severity of bleeding can be increased when Cloricromen is combined with Palbociclib.
Tasosartan
Picotamide
The risk or severity of bleeding can be increased when Picotamide is combined with Palbociclib.
Tasosartan
Ramatroban
The risk or severity of bleeding can be increased when Ramatroban is combined with Palbociclib.